Statin, like aspirin, should be given as early as possible in patients with acute coronary syndrome

Medical Hypotheses

Volumn 64, Issue 1, 2005, Pages 192-196

  Fang, Chun Hong ^a   Li, Jian Jun ^a,b   Hui, Rui Tai ^c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b TSINGHUA UNIVERSITY   (China)

^c FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; STATIN;

ADVENTITIA; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY DISEASE; DRUG EFFECT; HUMAN; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MONOCYTE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; THROMBUS; UNITED STATES;

THROMBUS;

EID: 7944227722     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.06.018     Document Type: Article

References (35)

1. A. Maseri Inflammation, atherosclerosis, and ischemic events: exploring the hidden side of the noon N. Engl. J. Med. 336 1997 1014 1016
2. Li J-J. Atheroscleritis is a more rational term for the pathological entity currently known as atherosclerosis. Med Hypotheses 2004;62 [in press]
3. R. Ross Atherosclerosis - an inflammatory disease N. Engl. J. Med. 340 1999 115 126
4. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin and risks of cardiovascular disease in apparently healthy men N. Engl. J. Med. 336 1997 973 979
5. P. Libby, and P.M. Ridker Novel inflammatory markers of coronary risk: theory versus practice Circulation 100 1999 1148 1150
6. P.M. Ridker High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease Circulation 103 2001 1813 1818
7. J.-.J. Li, H. Jiang, and C.X. Huang Elevated levels of plasma C-reactive protein in patients with unstable angina: its relations with coronary stenosis and lipid profile Angiology 53 2002 265 272
8. Li J-J, Fang C-H, Huang C-X, et al. Activation of NF-κB and associated with elevated C-reactive protein in patients with unstable angina. Heart Lung and Circulation 2004;13 [in press]
9. Li J-J, Fang C-H, Huang C-X, et al. Increased C-reactive protein level after renal stent implantation in patients with atherosclerotic renal stenosis. Angiology 2004;55 [in press]
10. J.-.J. Li C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular disease Med. Hypotheses 62 2004 499 506
11. J.-.J. Li Silent myocardial ischemia may be related to inflammatory response Med. Hypotheses 62 2004 252 256
12. S.D. Ferranti, and N. Rifai C-reactive protein and cardiovascular disease: a review of risk prediction and interventions Clin. Chim. Acta 317 2002 1 15
13. R.S. Schwartz, A. Bayes-Genis, and J.R. Lesser Detecting vulnerable plaque using peripheral blood: inflammatory and cellular markers J. Intervent. Cardiol. 16 2003 231 242
14. J.E. Muller, G.S. Abela, and R.W. Nesto Triggers, acute risk factors and vulnerable plaque: the lexicon of a new frontier J. Am. Coll. Cardiol. 23 1994 809 813
15. J.-.J. Li, and X.-.J. Chen Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein as well as lipopolysaccharide Coronary Artery Dis. 14 2003 329 334
16. J.-.J. Li Rapid effects on lipid profile and C-reactive protein by simvastatin in patients with hypercholesterolemia Clin. Cardiol. 26 2003 472 476
17. Li J-J, Fang C-H. Effect of a single high-dose of simvastatin on C-reactive protein in patients with unstable angina. HeartDrug 2004;4 [in press]
18. G. Jackson The role of statins in acute coronary syndromes: managing the unmet need Int. J. Clin. Pract. 54 2000 445 449
19. T.D. Szucs Pharmaco-economic aspects of lipid-lowering therapy: is it worth the price Eur. Heart J. 19 Suppl. M 1998 M22 M28
20. K. Fairhurst, and G. Huby From trial data to practical knowledge: qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia BMJ 317 1998 1130 1134
21. R.R. Azar, D.D. Waters, and B. Lebanon PRINCE's prospects: statin, inflammation, and coronary risk Am. Heart J. 141 2001 881 883
22. C.B. Treasure, J.L. Klein, and W.S. Weintraub Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease N. Engl. J. Med. 332 1995 481 487
23. H.G. Schrott, H. Knapp, and M. Davila Effect of atorvastatin on blood lipid levels in the first 2 weeks of treatment: a randomized, placebo-controlled study Am. Heart J. 140 2000 249 252
24. P.M. Ridker, N. Rifai, and S.P. Lowenthal Rapid reduction in C-reactive with cerivastatin among 785 patients with primary hypercholesterolemia Circulation 103 2001 1191 1193
25. J.K. Plenge, T.L. Hernandez, and K.M. Weil Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction Circulation 106 2002 1447 1452
26. P.M. Ridker, N. Rifai, and M.A. Pfeffer for the cholesterol and recurrent events CARE investigators. Long-term effects of pravastatin on plasma concentration of C-reactive protein Circulation 100 1999 230 235
27. P.M. Ridker, N. Rifai, and M.A. Pfeffer Long-term effects of pravastatin on plasma concentration of C-reactive protein Circulation 100 1999 230 235
28. P. Ostadal, D. Alan, and P. Hajek The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction Mol. Cell Biochem. 246 2003 45 50
29. D.J. Lefer, R. Scalia, and S.P. Jones Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts Circulation 100 1999 178 184
30. L. Diomede In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products Arterioscler. Thromb. Vasc. Biol. 21 2001 1327 1332
31. M. Kimura Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats Arterioscler. Thromb. Vasc. Biol. 17 1997 1521 1526
32. T.J. Stalker A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid Br. J. Pharmacol. 133 2001 406 412
33. C.P. Sparrow Simvastatin has anti-inflammatory and anti-atherosclerotic activities independent of plasma cholesterol lowering Arterioscler. Thromb. Vasc. Biol. 21 2001 115 121
34. M.A. Maggard Effects of pravastatin on chronic rejection of rat cardiac allografts Transplantation 65 1998 149 155
35. R. Stanislaus Lovastatin treatment decrease mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis J. Neurosci. Res. 66 2001 155 162